Mellinghoff, Sibylle C.
Hartmann, Pia
Cornely, Florian B.
Knauth, Laura
Köhler, Felix
Köhler, Philipp
Krause, Carolin
Kronenberg, Christine
Kranz, Sarah-Leonie
Menon, Vidya
Müller, Hannah
Naendrup, Jan-Hendrik
Pützfeld, Stefan
Ronge, Anna
Rutz, Jule
Seidel, Danila
Wisplinghoff, Hilmar
Cornely, Oliver A.
Article History
Received: 24 April 2018
Accepted: 15 May 2018
First Online: 13 June 2018
Compliance with ethical standards
:
: OAC is supported by the German Federal Ministry of Research and Education and the European Commission and has received research grants from, is an advisor to, or received lecture honoraria from Actelion, Amplyx, Arsanis, Astellas, AstraZeneca, Basilea, Cidara, Da Volterra, Duke University (NIH UM1AI104681), F2G, Gilead, GSK, Janssen, Leeds University, Matinas, Medicines Company, MedPace, Menarini, Merck/MSD, Miltenyi, Paratek, Pfizer, PSI, Rempex, Roche, Sanofi Pasteur, Scynexis, Seres, Summit, Tetraphase, and Vical. FCK reports grants from the German Federal Ministry of Research and Education, and non-financial support from Miltenyi Biotec GmbH. PK reports non-financial support from Merck/MSD, non-financial support from MedImmune, and lecture honoraria from Astellas, outside the submitted work. HW has received research grants from, is an advisor to, or received lecture honoraria from the German Society for Hematology/Oncology, BeckmanCoulter, BrukerDaltonics, BioMérieux, Hologic, Siemens, BioMérieux, Cepheid, Hologic, iSense, r-biopharm, and SpecificTechnologies. All remaining authors have declared no conflicts of interest.